Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.
Heise T, DeVries JH, Urva S, Li J, Pratt EJ, Thomas MK, Mather KJ, Karanikas CA, Dunn J, Haupt A, Milicevic Z, Coskun T.
Heise T, et al.
Diabetes Care. 2023 May 1;46(5):998-1004. doi: 10.2337/dc22-1710.
Diabetes Care. 2023.
PMID: 36857477
Free PMC article.
Clinical Trial.